Top compounds associated with response to EMC6


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 6e-08
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.18 4e-07
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 4e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 4e-06
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 5e-06
mRNA PX-12 CTRPv2 pan-cancer AAC -0.12 2e-05
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.16 2e-05
mRNA Doxorubicin gCSI pan-cancer AAC 0.22 3e-05
Download CSV